Skip to main content
Top

Pituitary

Issue 2/2003

Content (7 Articles)

Regulation of Corticotropin Releasing Hormone Receptor (CRH-R) in the Rat Anterior Pituitary as Assessed by Radioimmunoassay

Takeshi Nigawara, Nobuo Horiba, Fumiko Tozawa, Yoko Kasagi, Katsuya Uchida, Yasumasa Iwasaki, Toshihiro Suda

G Protein Mutations in Pituitary Tumors: A Study on Turkish Patients

Beki Kan, Christopher Esapa, Tammam Sipahi, Cevdet Nacar, Fahir Özer, Nur Buyru Sayhan, Mehmet Yaşar Kaynar, Ali Çetin Sarıoğlu, Philip Edward Harris

Quality of Life in Patients with a Pituitary Adenoma

Michelle D. Johnson, C.J. Woodburn, Mary Lee Vance

Development of New Prolactin Analogs Acting as Pure Prolactin Receptor Antagonists

Vincent Goffin, Sophie Bernichtein, Christine Kayser, Paul A. Kelly

Effects of Growth Hormone and Prolactin on Adipose Tissue Development and Function

David J. Flint, Nadine Binart, John Kopchick, Paul Kelly

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine